nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP1A2—Methimazole—Graves' disease	0.334	0.656	CbGbCtD
Bromocriptine—CYP3A4—Methimazole—Graves' disease	0.175	0.344	CbGbCtD
Bromocriptine—DRD5—eyelid—Graves' disease	0.0967	0.538	CbGeAlD
Bromocriptine—Lung infiltration—Propylthiouracil—Graves' disease	0.0325	0.163	CcSEcCtD
Bromocriptine—Vasculitis—Propylthiouracil—Graves' disease	0.0156	0.0781	CcSEcCtD
Bromocriptine—Drowsiness—Methimazole—Graves' disease	0.01	0.0501	CcSEcCtD
Bromocriptine—Drowsiness—Propylthiouracil—Graves' disease	0.00853	0.0426	CcSEcCtD
Bromocriptine—Alopecia—Methimazole—Graves' disease	0.00796	0.0398	CcSEcCtD
Bromocriptine—Vertigo—Methimazole—Graves' disease	0.00705	0.0352	CcSEcCtD
Bromocriptine—Alopecia—Propylthiouracil—Graves' disease	0.00677	0.0338	CcSEcCtD
Bromocriptine—Dysgeusia—Propylthiouracil—Graves' disease	0.00653	0.0326	CcSEcCtD
Bromocriptine—HTR1D—eye—Graves' disease	0.00645	0.0359	CbGeAlD
Bromocriptine—Oedema—Methimazole—Graves' disease	0.0064	0.032	CcSEcCtD
Bromocriptine—HTR1D—connective tissue—Graves' disease	0.00622	0.0346	CbGeAlD
Bromocriptine—ADRB1—connective tissue—Graves' disease	0.00604	0.0336	CbGeAlD
Bromocriptine—Vertigo—Propylthiouracil—Graves' disease	0.00599	0.0299	CcSEcCtD
Bromocriptine—Paraesthesia—Methimazole—Graves' disease	0.00575	0.0287	CcSEcCtD
Bromocriptine—Somnolence—Methimazole—Graves' disease	0.00569	0.0284	CcSEcCtD
Bromocriptine—Dyspepsia—Methimazole—Graves' disease	0.00563	0.0282	CcSEcCtD
Bromocriptine—Oedema—Propylthiouracil—Graves' disease	0.00544	0.0272	CcSEcCtD
Bromocriptine—Urticaria—Methimazole—Graves' disease	0.00508	0.0254	CcSEcCtD
Bromocriptine—Body temperature increased—Methimazole—Graves' disease	0.00506	0.0253	CcSEcCtD
Bromocriptine—HTR7—connective tissue—Graves' disease	0.00495	0.0275	CbGeAlD
Bromocriptine—Paraesthesia—Propylthiouracil—Graves' disease	0.00489	0.0244	CcSEcCtD
Bromocriptine—DRD2—eye—Graves' disease	0.00486	0.027	CbGeAlD
Bromocriptine—Somnolence—Propylthiouracil—Graves' disease	0.00484	0.0242	CcSEcCtD
Bromocriptine—Dyspepsia—Propylthiouracil—Graves' disease	0.00479	0.0239	CcSEcCtD
Bromocriptine—ADRB1—adipose tissue—Graves' disease	0.00464	0.0258	CbGeAlD
Bromocriptine—HTR2B—adipose tissue—Graves' disease	0.00444	0.0247	CbGeAlD
Bromocriptine—Urticaria—Propylthiouracil—Graves' disease	0.00432	0.0216	CcSEcCtD
Bromocriptine—Body temperature increased—Propylthiouracil—Graves' disease	0.0043	0.0215	CcSEcCtD
Bromocriptine—Vomiting—Methimazole—Graves' disease	0.00407	0.0203	CcSEcCtD
Bromocriptine—Rash—Methimazole—Graves' disease	0.00404	0.0202	CcSEcCtD
Bromocriptine—Dermatitis—Methimazole—Graves' disease	0.00403	0.0201	CcSEcCtD
Bromocriptine—Headache—Methimazole—Graves' disease	0.00401	0.02	CcSEcCtD
Bromocriptine—HTR2B—thyroid gland—Graves' disease	0.00384	0.0214	CbGeAlD
Bromocriptine—Nausea—Methimazole—Graves' disease	0.0038	0.019	CcSEcCtD
Bromocriptine—ADRA1A—adipose tissue—Graves' disease	0.00367	0.0204	CbGeAlD
Bromocriptine—ADRA2A—connective tissue—Graves' disease	0.00363	0.0202	CbGeAlD
Bromocriptine—DRD2—pituitary gland—Graves' disease	0.00361	0.0201	CbGeAlD
Bromocriptine—ADRA2C—pituitary gland—Graves' disease	0.00351	0.0195	CbGeAlD
Bromocriptine—ADRA2C—adipose tissue—Graves' disease	0.00349	0.0194	CbGeAlD
Bromocriptine—Vomiting—Propylthiouracil—Graves' disease	0.00346	0.0173	CcSEcCtD
Bromocriptine—Rash—Propylthiouracil—Graves' disease	0.00343	0.0171	CcSEcCtD
Bromocriptine—Dermatitis—Propylthiouracil—Graves' disease	0.00343	0.0171	CcSEcCtD
Bromocriptine—Headache—Propylthiouracil—Graves' disease	0.00341	0.017	CcSEcCtD
Bromocriptine—Nausea—Propylthiouracil—Graves' disease	0.00323	0.0162	CcSEcCtD
Bromocriptine—HTR2A—eye—Graves' disease	0.00321	0.0178	CbGeAlD
Bromocriptine—HTR2A—connective tissue—Graves' disease	0.00309	0.0172	CbGeAlD
Bromocriptine—ADRA2A—pituitary gland—Graves' disease	0.0028	0.0156	CbGeAlD
Bromocriptine—ADRA2A—adipose tissue—Graves' disease	0.00279	0.0155	CbGeAlD
Bromocriptine—CYP1A2—thyroid gland—Graves' disease	0.00262	0.0146	CbGeAlD
Bromocriptine—ADRA2A—thyroid gland—Graves' disease	0.00241	0.0134	CbGeAlD
Bromocriptine—HTR2A—pituitary gland—Graves' disease	0.00238	0.0132	CbGeAlD
Bromocriptine—ABCB1—pituitary gland—Graves' disease	0.00156	0.00867	CbGeAlD
Bromocriptine—ABCB1—adipose tissue—Graves' disease	0.00155	0.00864	CbGeAlD
Bromocriptine—ABCB1—thyroid gland—Graves' disease	0.00134	0.00747	CbGeAlD
Bromocriptine—ADRA2C—GPCR ligand binding—TSHR—Graves' disease	0.000285	0.00257	CbGpPWpGaD
Bromocriptine—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	0.000282	0.00255	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR ligand binding—TSHR—Graves' disease	0.00028	0.00253	CbGpPWpGaD
Bromocriptine—DRD2—G alpha (i) signalling events—CXCL10—Graves' disease	0.000276	0.00249	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—TSHR—Graves' disease	0.000264	0.00239	CbGpPWpGaD
Bromocriptine—ADRA2B—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000261	0.00236	CbGpPWpGaD
Bromocriptine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000261	0.00236	CbGpPWpGaD
Bromocriptine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000259	0.00234	CbGpPWpGaD
Bromocriptine—DRD2—GPCR ligand binding—TSHR—Graves' disease	0.000258	0.00233	CbGpPWpGaD
Bromocriptine—HTR6—GPCR ligand binding—CXCL10—Graves' disease	0.000257	0.00232	CbGpPWpGaD
Bromocriptine—HTR7—GPCR ligand binding—CXCL10—Graves' disease	0.000256	0.00232	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR ligand binding—CXCL10—Graves' disease	0.000255	0.0023	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR ligand binding—TSHR—Graves' disease	0.000254	0.0023	CbGpPWpGaD
Bromocriptine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000253	0.00229	CbGpPWpGaD
Bromocriptine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00025	0.00226	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR ligand binding—CXCL10—Graves' disease	0.000249	0.00225	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR ligand binding—TSHR—Graves' disease	0.000249	0.00225	CbGpPWpGaD
Bromocriptine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000248	0.00224	CbGpPWpGaD
Bromocriptine—ADRA2A—G alpha (i) signalling events—CXCL10—Graves' disease	0.000247	0.00223	CbGpPWpGaD
Bromocriptine—DRD4—GPCR ligand binding—CXCL10—Graves' disease	0.000245	0.00222	CbGpPWpGaD
Bromocriptine—ADRA2C—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000244	0.0022	CbGpPWpGaD
Bromocriptine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000241	0.00218	CbGpPWpGaD
Bromocriptine—DRD2—Circadian rythm related genes—FAS—Graves' disease	0.00024	0.00217	CbGpPWpGaD
Bromocriptine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000238	0.00215	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR ligand binding—CXCL10—Graves' disease	0.000234	0.00212	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—TSHR—Graves' disease	0.000231	0.00209	CbGpPWpGaD
Bromocriptine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.000226	0.00204	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—TSHR—Graves' disease	0.000225	0.00203	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—TSHR—Graves' disease	0.000224	0.00203	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—TSHR—Graves' disease	0.000223	0.00201	CbGpPWpGaD
Bromocriptine—DRD1—GPCR ligand binding—CXCL10—Graves' disease	0.000221	0.002	CbGpPWpGaD
Bromocriptine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000219	0.00198	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—TSHR—Graves' disease	0.000218	0.00197	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR ligand binding—CXCL10—Graves' disease	0.000218	0.00197	CbGpPWpGaD
Bromocriptine—DRD3—GPCR ligand binding—CXCL10—Graves' disease	0.000218	0.00197	CbGpPWpGaD
Bromocriptine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000216	0.00195	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—TSHR—Graves' disease	0.000215	0.00194	CbGpPWpGaD
Bromocriptine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000211	0.00191	CbGpPWpGaD
Bromocriptine—ABCB1—Allograft Rejection—IFNG—Graves' disease	0.000206	0.00186	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—TSHR—Graves' disease	0.000205	0.00185	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—TSHR—Graves' disease	0.000204	0.00184	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—TSHR—Graves' disease	0.000204	0.00184	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—TSHR—Graves' disease	0.000202	0.00183	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR ligand binding—CXCL10—Graves' disease	0.000199	0.0018	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—TSHR—Graves' disease	0.000198	0.00179	CbGpPWpGaD
Bromocriptine—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000198	0.00179	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR ligand binding—CXCL10—Graves' disease	0.000197	0.00178	CbGpPWpGaD
Bromocriptine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000196	0.00177	CbGpPWpGaD
Bromocriptine—HTR1A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000196	0.00177	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—TSHR—Graves' disease	0.000195	0.00176	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—TSHR—Graves' disease	0.000193	0.00175	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—TSHR—Graves' disease	0.000191	0.00172	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—TSHR—Graves' disease	0.000191	0.00172	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR ligand binding—CXCL10—Graves' disease	0.00019	0.00172	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR ligand binding—CXCL10—Graves' disease	0.000189	0.00171	CbGpPWpGaD
Bromocriptine—DRD5—GPCR downstream signaling—CXCL10—Graves' disease	0.000188	0.0017	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—TSHR—Graves' disease	0.000186	0.00168	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR ligand binding—CXCL10—Graves' disease	0.000184	0.00166	CbGpPWpGaD
Bromocriptine—ABCB1—Allograft Rejection—IL1B—Graves' disease	0.000184	0.00166	CbGpPWpGaD
Bromocriptine—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000183	0.00166	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR ligand binding—CXCL10—Graves' disease	0.000181	0.00164	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—TSHR—Graves' disease	0.000176	0.00159	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—TSHR—Graves' disease	0.000174	0.00157	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—TSHR—Graves' disease	0.000173	0.00157	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—TSHR—Graves' disease	0.000173	0.00157	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—TSHR—Graves' disease	0.000172	0.00156	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—CXCL10—Graves' disease	0.000171	0.00154	CbGpPWpGaD
Bromocriptine—HTR2A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000169	0.00153	CbGpPWpGaD
Bromocriptine—DRD2—GPCR ligand binding—CXCL10—Graves' disease	0.000167	0.00151	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—TSHR—Graves' disease	0.000166	0.0015	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000165	0.0015	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—TSHR—Graves' disease	0.000165	0.00149	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—GC—Graves' disease	0.000164	0.00149	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR ligand binding—CXCL10—Graves' disease	0.000164	0.00148	CbGpPWpGaD
Bromocriptine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000164	0.00148	CbGpPWpGaD
Bromocriptine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000164	0.00148	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—TSHR—Graves' disease	0.000161	0.00145	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR ligand binding—CXCL10—Graves' disease	0.000161	0.00145	CbGpPWpGaD
Bromocriptine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000161	0.00145	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—TSHR—Graves' disease	0.000158	0.00143	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—TSHR—Graves' disease	0.000158	0.00143	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—TSHR—Graves' disease	0.000156	0.00141	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TSHR—Graves' disease	0.000156	0.00141	CbGpPWpGaD
Bromocriptine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000155	0.0014	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—TSHR—Graves' disease	0.000151	0.00136	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—TSHR—Graves' disease	0.00015	0.00136	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	0.000149	0.00135	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—TSHR—Graves' disease	0.000146	0.00132	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—TSHR—Graves' disease	0.000146	0.00132	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—CXCL10—Graves' disease	0.000145	0.00131	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—CXCL10—Graves' disease	0.000145	0.00131	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—CXCL10—Graves' disease	0.000144	0.0013	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—TSHR—Graves' disease	0.000144	0.0013	CbGpPWpGaD
Bromocriptine—DRD5—GPCR downstream signaling—IL2RA—Graves' disease	0.000144	0.0013	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—TSHR—Graves' disease	0.000144	0.0013	CbGpPWpGaD
Bromocriptine—HTR1A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000142	0.00129	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—CXCL10—Graves' disease	0.000141	0.00127	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—TSHR—Graves' disease	0.000141	0.00127	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—CXCL10—Graves' disease	0.000139	0.00125	CbGpPWpGaD
Bromocriptine—ADRA2B—Hemostasis—IL2RA—Graves' disease	0.000135	0.00122	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—GC—Graves' disease	0.000133	0.00121	CbGpPWpGaD
Bromocriptine—ABCB1—Allograft Rejection—TNF—Graves' disease	0.000133	0.0012	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—TSHR—Graves' disease	0.000133	0.0012	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—CXCL10—Graves' disease	0.000132	0.0012	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—CXCL10—Graves' disease	0.000132	0.00119	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—CXCL10—Graves' disease	0.000132	0.00119	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—CXCL10—Graves' disease	0.000131	0.00118	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	0.000131	0.00118	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—IL2RA—Graves' disease	0.00013	0.00118	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—TSHR—Graves' disease	0.00013	0.00118	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—CXCL10—Graves' disease	0.000128	0.00116	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—TSHR—Graves' disease	0.000128	0.00115	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—CXCL10—Graves' disease	0.000126	0.00114	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—IL2RA—Graves' disease	0.000126	0.00114	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—CXCL10—Graves' disease	0.000125	0.00113	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—B3GNT2—Graves' disease	0.000125	0.00113	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—CXCL10—Graves' disease	0.000123	0.00111	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—CXCL10—Graves' disease	0.000123	0.00111	CbGpPWpGaD
Bromocriptine—HTR2A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000123	0.00111	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TSHR—Graves' disease	0.00012	0.00109	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TSHR—Graves' disease	0.00012	0.00109	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—CXCL10—Graves' disease	0.00012	0.00109	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TSHR—Graves' disease	0.00012	0.00108	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	0.000119	0.00107	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TSHR—Graves' disease	0.000117	0.00106	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TSHR—Graves' disease	0.000115	0.00104	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—CXCL10—Graves' disease	0.000113	0.00103	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—CXCL10—Graves' disease	0.000112	0.00101	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—CXCL10—Graves' disease	0.000112	0.00101	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—CXCL10—Graves' disease	0.000112	0.00101	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—CXCL10—Graves' disease	0.000111	0.00101	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—IL2RA—Graves' disease	0.000111	0.001	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—IL2RA—Graves' disease	0.000111	0.001	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—IL2RA—Graves' disease	0.00011	0.000995	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TSHR—Graves' disease	0.00011	0.000994	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—IL2RA—Graves' disease	0.000108	0.000974	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—CXCL10—Graves' disease	0.000107	0.000971	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—CXCL10—Graves' disease	0.000107	0.000966	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—IL2RA—Graves' disease	0.000106	0.000958	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—CXCL10—Graves' disease	0.000104	0.000939	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TSHR—Graves' disease	0.000104	0.000937	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TSHR—Graves' disease	0.000102	0.000925	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TSHR—Graves' disease	0.000102	0.000925	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—CXCL10—Graves' disease	0.000102	0.000924	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—IL2RA—Graves' disease	0.000102	0.000923	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—CXCL10—Graves' disease	0.000102	0.000922	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—IL2RA—Graves' disease	0.000101	0.000915	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—B3GNT2—Graves' disease	0.000101	0.000914	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—CXCL10—Graves' disease	0.000101	0.000913	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—CXCL10—Graves' disease	0.000101	0.000911	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—IL2RA—Graves' disease	0.000101	0.00091	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—IL2RA—Graves' disease	0.000101	0.000909	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—IL2RA—Graves' disease	9.99e-05	0.000903	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—IL2RA—Graves' disease	9.78e-05	0.000884	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—CXCL10—Graves' disease	9.75e-05	0.000882	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—CXCL10—Graves' disease	9.7e-05	0.000877	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—IL2RA—Graves' disease	9.63e-05	0.00087	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—IL2RA—Graves' disease	9.55e-05	0.000863	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—CXCL10—Graves' disease	9.44e-05	0.000853	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—CXCL10—Graves' disease	9.43e-05	0.000852	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—IL2RA—Graves' disease	9.42e-05	0.000851	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—IL2RA—Graves' disease	9.42e-05	0.000851	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TSHR—Graves' disease	9.32e-05	0.000843	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—CXCL10—Graves' disease	9.29e-05	0.00084	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—CXCL10—Graves' disease	9.28e-05	0.000839	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TSHR—Graves' disease	9.24e-05	0.000835	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—GC—Graves' disease	9.23e-05	0.000834	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—IL2RA—Graves' disease	9.19e-05	0.000831	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—CXCL10—Graves' disease	9.08e-05	0.000821	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TSHR—Graves' disease	8.92e-05	0.000806	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TSHR—Graves' disease	8.87e-05	0.000802	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—IL2RA—Graves' disease	8.67e-05	0.000784	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TSHR—Graves' disease	8.63e-05	0.00078	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—IL2RA—Graves' disease	8.58e-05	0.000776	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—CXCL10—Graves' disease	8.56e-05	0.000774	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—IL2RA—Graves' disease	8.55e-05	0.000773	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—IL2RA—Graves' disease	8.55e-05	0.000773	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—IL2RA—Graves' disease	8.5e-05	0.000769	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TSHR—Graves' disease	8.49e-05	0.000767	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	8.44e-05	0.000763	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—CXCL10—Graves' disease	8.43e-05	0.000762	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—CXCL10—Graves' disease	8.25e-05	0.000746	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—IL2RA—Graves' disease	8.21e-05	0.000742	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—IL2RA—Graves' disease	8.17e-05	0.000738	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—IL2RA—Graves' disease	7.94e-05	0.000718	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TSHR—Graves' disease	7.83e-05	0.000708	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—IL2RA—Graves' disease	7.82e-05	0.000707	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—IL2RA—Graves' disease	7.79e-05	0.000704	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CXCL10—Graves' disease	7.78e-05	0.000704	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CXCL10—Graves' disease	7.77e-05	0.000703	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CXCL10—Graves' disease	7.72e-05	0.000698	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—IL2RA—Graves' disease	7.72e-05	0.000698	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IL2RA—Graves' disease	7.71e-05	0.000697	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TSHR—Graves' disease	7.7e-05	0.000696	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	7.67e-05	0.000693	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CXCL10—Graves' disease	7.56e-05	0.000684	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TSHR—Graves' disease	7.54e-05	0.000682	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL2RA—Graves' disease	7.45e-05	0.000674	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CXCL10—Graves' disease	7.44e-05	0.000673	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL2RA—Graves' disease	7.42e-05	0.00067	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GC—Graves' disease	7.37e-05	0.000666	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL2RA—Graves' disease	7.21e-05	0.000652	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—IL2RA—Graves' disease	7.21e-05	0.000651	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CXCL10—Graves' disease	7.1e-05	0.000642	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL2RA—Graves' disease	7.1e-05	0.000642	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—IL2RA—Graves' disease	7.09e-05	0.000641	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TSHR—Graves' disease	7.01e-05	0.000633	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—B3GNT2—Graves' disease	6.99e-05	0.000632	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—IL2RA—Graves' disease	6.94e-05	0.000628	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CXCL10—Graves' disease	6.7e-05	0.000606	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CXCL10—Graves' disease	6.61e-05	0.000598	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CXCL10—Graves' disease	6.61e-05	0.000598	CbGpPWpGaD
Bromocriptine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	6.57e-05	0.000594	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL2RA—Graves' disease	6.54e-05	0.000592	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	6.45e-05	0.000583	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL2RA—Graves' disease	6.44e-05	0.000582	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL2RA—Graves' disease	6.31e-05	0.00057	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CXCL10—Graves' disease	6.02e-05	0.000544	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CXCL10—Graves' disease	5.97e-05	0.000539	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL2RA—Graves' disease	5.95e-05	0.000538	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL2RA—Graves' disease	5.94e-05	0.000537	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL2RA—Graves' disease	5.9e-05	0.000534	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	5.86e-05	0.00053	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL2RA—Graves' disease	5.78e-05	0.000522	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CXCL10—Graves' disease	5.76e-05	0.000521	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CXCL10—Graves' disease	5.73e-05	0.000518	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL2RA—Graves' disease	5.69e-05	0.000514	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GC—Graves' disease	5.69e-05	0.000514	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—B3GNT2—Graves' disease	5.58e-05	0.000505	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CXCL10—Graves' disease	5.57e-05	0.000504	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CXCL10—Graves' disease	5.49e-05	0.000496	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL2RA—Graves' disease	5.43e-05	0.000491	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL2RA—Graves' disease	5.12e-05	0.000463	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CXCL10—Graves' disease	5.06e-05	0.000457	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL2RA—Graves' disease	5.05e-05	0.000457	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL2RA—Graves' disease	5.05e-05	0.000457	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CXCL10—Graves' disease	4.98e-05	0.00045	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CXCL10—Graves' disease	4.87e-05	0.000441	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL2RA—Graves' disease	4.6e-05	0.000416	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL2RA—Graves' disease	4.56e-05	0.000412	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	4.53e-05	0.000409	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL2RA—Graves' disease	4.4e-05	0.000398	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL2RA—Graves' disease	4.38e-05	0.000396	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—B3GNT2—Graves' disease	4.31e-05	0.000389	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL2RA—Graves' disease	4.26e-05	0.000385	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL2RA—Graves' disease	4.19e-05	0.000379	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2RA—Graves' disease	3.87e-05	0.000349	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2RA—Graves' disease	3.8e-05	0.000344	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2RA—Graves' disease	3.72e-05	0.000337	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	3.46e-05	0.000313	CbGpPWpGaD
